Cardiovascular Drugs and Therapy focuses on the most exciting new therapeutic agent research, including hyperlipidemia, diabetes, and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias. These include mechanisms of action and signalling pathways, their potential for new drug development, novel indications for existing drugs, genetic approaches to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as their use in real-world patient populations based on guidelines. The Journal is an authoritative source of current and relevant information that is essential for basic and clinical investigators seeking novel, breakthrough research, as well as cardiologists seeking to provide the best possible care to their patients.
Read More:
https://cmitoc.blogspot.com/2022/07/cardiovascular-drugs-are-used-to-treat.html
